All In Biotech

Investigational drug · Phase 2

LY3972406

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Plaque Psoriasis.

Phase 2

Last checked: Nov 19, 2026Latest source record: Oct 15, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

0 still active

All registered trials

1

Any phase or sponsor naming "LY3972406"

First trial start

2023

Dec 6, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "LY3972406", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Plaque Psoriasis

Approved drugs for the same conditions: Plaque psoriasis · Immunology and inflammation

Largest trials

Live from ClinicalTrials.gov: studies naming "LY3972406" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 1 on PubMed

Also in development for Plaque Psoriasis

  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • EnvudeucitinibPhase 34 trials

    Alumis Inc · Plaque Psoriasis, SLE

  • ICP-332Phase 34 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Non Segmental Vitiligo, Chronic Spontaneous Urticaria (CSU), Atopic Dermatitis

  • TQH3906Phase 34 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Psoriasis, Systemic Lupus Erythematosus, Psoriatic Arthritis

  • NetakimabPhase 32 trials

    Biocad · Plaque Psoriasis

  • PicankibartPhase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Psoriatic Arthritis, Plaque Psoriasis

  • piclidenosonPhase 32 trials

    Can-Fite BioPharma · Plaque Psoriasis, Lowe Syndrome

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Eli Lilly.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.